Yoshinori Minami
Overview
Explore the profile of Yoshinori Minami including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
673
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Exceptional Response to PD-1 Blockade as First-Line Therapy in Head and Neck Squamous Cell Carcinoma
Kumai T, Komatsuda H, Minami Y, Harabuchi Y
ORL J Otorhinolaryngol Relat Spec
. 2020 Sep;
82(6):343-350.
PMID: 32882699
The effect of PD-1 blockade as a first-line therapy in nonmetastatic head and neck squamous cell carcinoma (HNSCC) remains unknown. We report a case of an exceptional response to PD-1...
12.
Yokouchi H, Nishihara H, Harada T, Yamazaki S, Kikuchi H, Oizumi S, et al.
Heliyon
. 2020 Jul;
6(7):e04439.
PMID: 32685741
Objectives: Few reports have explored clinical biomarkers, including those identified by targeted exome sequencing (TES) of surgically resected small-cell lung cancer (SCLC) and correlation with patient survival. Patients And Methods:...
13.
Umekage Y, Okumura S, Tenma T, Kazebayashi Y, Hirai N, Minami Y, et al.
Respir Med Case Rep
. 2020 Jul;
31:101143.
PMID: 32676278
Acute eosinophilic pneumonia (AEP) is an eosinophilic lung disease associated with environmental substances including smoking. Although the etiology of AEP has not been fully elucidated, it has been hypothesized that...
14.
Zhao J, Dar H, Deng Y, St Croix C, Li Z, Minami Y, et al.
Proc Natl Acad Sci U S A
. 2020 Jun;
117(25):14376-14385.
PMID: 32513718
Temporally harmonized elimination of damaged or unnecessary organelles and cells is a prerequisite of health. Under Type 2 inflammatory conditions, human airway epithelial cells (HAECs) generate proferroptotic hydroperoxy-arachidonoyl-phosphatidylethanolamines (HpETE-PEs) as...
15.
Hirai N, Sasaki T, Okumura S, Minami Y, Chiba S, Ohsaki Y
Front Oncol
. 2020 Apr;
10:419.
PMID: 32300555
Oncogenic echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase () (EML4-ALK) fusion proteins found in non-small cell lung cancers (NSCLC) are constitutively phosphorylated and activated by dimerization via the coiled-coil domain...
16.
Furuta M, Sakakibara-Konishi J, Kikuchi H, Yokouchi H, Nishihara H, Minemura H, et al.
Oncologist
. 2019 May;
24(11):e1172-e1179.
PMID: 31068386
Background: Delta-like protein 3 (DLL3) is a Notch ligand that has an important role in the tumorigenesis of small cell lung cancer (SCLC). Recently, rovalpituzumab tesirine (Rova-T), a DLL3-targeted antibody-drug...
17.
Narumi Y, Yoshida R, Minami Y, Yamamoto Y, Takeguchi S, Kano K, et al.
BMC Cancer
. 2018 Jan;
18(1):95.
PMID: 29361915
Background: Immune checkpoint blockade is developed as standard treatment for non-small cell lung cancer. However immune-related adverse events (irAE) have still unknown complications. Here, we report a patient with lung...
18.
Wenzel S, Tyurina Y, Zhao J, St Croix C, Dar H, Mao G, et al.
Cell
. 2017 Oct;
171(3):628-641.e26.
PMID: 29053969
Ferroptosis is a form of programmed cell death that is pathogenic to several acute and chronic diseases and executed via oxygenation of polyunsaturated phosphatidylethanolamines (PE) by 15-lipoxygenases (15-LO) that normally...
19.
Yoshida R, Sasaki T, Minami Y, Hibino Y, Okumura S, Sado M, et al.
Int J Oncol
. 2017 Oct;
51(5):1533-1540.
PMID: 29048652
Anaplastic lymphoma kinase (ALK) fusion oncogenes occur in approximately 3-5% of non-small cell lung cancer (NSCLC) cases. Various ALK inhibitors are in clinical use for the treatment of ALK-NSCLC, including...
20.
Zhao J, Minami Y, Etling E, Coleman J, Lauder S, Tyrrell V, et al.
Am J Respir Cell Mol Biol
. 2017 Jul;
57(6):692-701.
PMID: 28723225
Type 2-associated goblet cell hyperplasia and mucus hypersecretion are well known features of asthma. 15-Lipoxygenase-1 (15LO1) is induced by the type 2 cytokine IL-13 in human airway epithelial cells (HAECs)...